V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260009487 | 260012274 | 1.65 | 89.1 | Curative (C) | 2016-04-03 | 2016-04-26 | Rituximab | N | N | 260029967 | RITUXIMAB |
| 260009488 | 260017456 | 1.71 | 86.2 | Curative (C) | 2017-09-13 | 2017-10-28 | Rituximab | N | N | 260029970 | BLEOMYCIN + CISPLATIN + ETOPOSIDE |
| 260009489 | 260006120 | 1.62 | null | Palliative (P) | 2018-01-01 | 2018-01-06 | DOXORUBICIN | 02 | N | 260029971 | CISPLATIN + ETOPOSIDE |
| 260009490 | 260006121 | 1.74 | 84 | Disease modification (D) | 2017-01-07 | 2017-01-27 | CISPLATIN + ETOPOSIDE | 02 | N | 260029973 | CISPLATIN + ETOPOSIDE |
| 260009491 | 260006121 | 1.79 | 57.6 | Curative (C) | 2015-09-24 | 2015-10-01 | EP | 02 | Y | 260029973 | RITUXIMAB |
| 260009492 | 260006122 | 1.77 | 88 | null | 2013-03-10 | 2013-03-10 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL | N | N | 260029975 | CISPLATIN + ETOPOSIDE |
| 260009493 | 260012276 | 0 | 104 | Palliative (P) | 2018-07-03 | 2018-07-03 | Rituximab | 2 | Y | 260029978 | RITUXIMAB |
| 260009494 | 260012276 | 1.82 | 81.9 | Disease modification (D) | 2013-02-02 | 2013-02-03 | Carboplatin + Paclitaxel (3 weekly) | 01 | N | 260029978 | RITUXIMAB |
| 260009495 | 260006123 | 1.73 | 80 | null | 2018-01-02 | 2018-01-03 | Cisplatin + Etoposide (5 day) | 02 | null | 260029983 | CISPLATIN + ETOPOSIDE |
| 260009496 | 260006123 | 1.77 | null | Disease modification (D) | 2015-01-23 | 2015-02-06 | PEMBROLIZUMAB | 02 | N | 260029983 | CARBOPLATIN + ETOPOSIDE |
| 260009497 | 260006124 | 0 | 84.8 | Disease modification (D) | 2015-04-19 | 2015-04-23 | Cisplatin + Etoposide (5 day) | 02 | N | 260029988 | CISPLATIN + ETOPOSIDE |
| 260009498 | 260006124 | 1.61 | 57 | Curative (C) | 2014-02-27 | 2014-02-27 | Bendamustine +/- Prednisolone | 2 | null | 260029988 | RITUXIMAB |
| 260009499 | 260006125 | null | 60 | Palliative (P) | null | 2014-01-14 | ETOPOSIDE + RITUXIMAB | null | null | 260029993 | CYCLOPHOSPHAMIDE + DOCETAXEL |
| 260009500 | 260006126 | 1.67 | 62 | Curative (C) | 2015-08-05 | 2015-08-16 | Carboplatin + Vinorelbine Oral | 02 | N | 260029998 | CISPLATIN |
| 260009501 | 260006126 | null | null | Radical (R) | 2014-10-19 | 2014-10-25 | Cisplatin + Etoposide (5 day) | N | N | 260029998 | CEB |
| 260009502 | 260006127 | 1.7 | 78.15 | null | 2014-01-19 | 2014-01-19 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | 02 | null | 260030004 | EP |
| 260009503 | 260006128 | 1.86 | 68.8 | Disease modification (D) | 2017-09-15 | 2017-09-19 | CISPLATIN + ETOPOSIDE | 2 | N | 260030005 | CARBOPLATIN + PEMETREXED |
| 260009504 | 260006128 | 1.63 | 52 | Palliative (P) | 2014-09-06 | 2014-09-12 | Rituximab | N | N | 260030005 | CISPLATIN + VINORELBINE |
| 260009505 | 260006128 | 1.62 | null | Palliative (P) | 2017-10-19 | 2017-11-06 | Carboplatin 21day + Paclitaxel 7day | 02 | N | 260030005 | RITUXIMAB |
| 260009506 | 260006128 | 0 | 108 | Neo-adjuvant (N) | 2013-08-08 | 2013-08-21 | Cisplatin + Etoposide (5 day) | N | N | 260030005 | TIP |
| 260009507 | 260006128 | 1.64 | null | Curative (C) | 2015-10-30 | 2015-11-12 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | N | 260030005 | BLEOMYCIN + VINCRISTINE |
| 260009508 | 260006128 | 1.64 | 66 | Curative (C) | 2014-08-23 | 2014-08-24 | Rituximab | N | N | 260030005 | RITUXIMAB |
| 260009509 | 260006129 | 1.7 | 132 | null | 2015-10-05 | 2015-10-09 | CISPLATIN + DACTINOMYCIN + ETOPOSIDE + FILGRASTIM + METHOTREXATE | N | N | 260030022 | CISPLATIN + ETOPOSIDE |
| 260009510 | 260012281 | null | 45.3 | Palliative (P) | 2016-01-13 | 2016-02-04 | CHOP - 21 days | 2 | N | 260030024 | RITUXIMAB |
| 260009511 | 260012281 | null | 71.5 | null | 2014-07-16 | 2014-08-19 | Rituximab | 1 | null | 260030024 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260009512 | 260006130 | null | 83 | Palliative (P) | 2014-11-17 | 2014-11-19 | Cisplatin + Etoposide (5 day) | N | N | 260030029 | CISPLATIN + ETOPOSIDE |
| 260009513 | 260012282 | 1.6 | 69 | null | 2015-02-09 | 2015-02-13 | Cisplatin + Pemetrexed | 2 | null | 260030030 | GEMCARBO |
| 260009514 | 260006131 | null | 71.65 | Curative (C) | 2016-02-05 | 2016-02-12 | GALLIUM TRIAL | N | N | 260030035 | TRIAL |
| 260009515 | 260006132 | 1.67 | 53.8 | Curative (C) | 2017-03-04 | 2017-03-10 | Cisplatin + Radiotherapy | N | N | 260030039 | TRIAL |
| 260009516 | 260006132 | 1.71 | 0 | Not known (9) | null | 2016-10-29 | Rituximab | N | null | 260030039 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260009517 | 260006132 | 1.67 | 56.7 | Palliative (P) | 2015-11-07 | 2015-11-10 | Chlorambucil + Pred + Rituximab | 02 | null | 260030039 | RITUXIMAB |
| 260009518 | 260017458 | null | 75.8 | null | 2017-12-24 | 2018-01-27 | 111 Trial (formerly BEP 111) | 2 | N | 260030043 | CISPLATIN + ETOPOSIDE |
| 260009519 | 260017458 | 1.72 | 78.1 | Curative (C) | null | 2013-10-30 | Cisplatin + Etoposide po&iv 3 day | null | null | 260030043 | NOT MATCHED |
| 260009520 | 260017458 | 1.67 | null | Curative (C) | 2016-12-21 | 2016-12-21 | Cisplatin + Etoposide (5 day) | Y | N | 260030043 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260009521 | 260017458 | 1.66 | 52 | Disease modification (D) | 2014-06-17 | 2014-07-01 | CISPLATIN + VINORELBINE | 2 | N | 260030043 | GEMCARBO |
| 260009522 | 260006133 | 1.52 | null | Palliative (P) | 2016-05-04 | 2016-05-04 | Rituximab | N | N | 260030055 | CHLORAMBUCIL |
| 260009523 | 260006133 | 1.88 | 63.2 | null | null | 2015-08-23 | 111 Trial (formerly BEP 111) | N | N | 260030055 | CARBOPLATIN + ETOPOSIDE |
| 260009524 | 260015662 | 1.73 | null | Palliative (P) | 2018-01-14 | 2018-03-16 | Carboplatin + Etoposide IV 3 day | Y | N | 260030065 | BCG |
| 260009525 | 260006134 | null | null | Palliative (P) | 2016-07-10 | 2016-07-20 | ECX | Y | N | 260030066 | CISPLATIN + ETOPOSIDE |
| 260009526 | 260006134 | 1.75 | null | Palliative (P) | 2015-11-08 | 2015-11-17 | CISPLATIN + ETOPOSIDE | N | N | 260030066 | NOT MATCHED |
| 260009527 | 260006135 | 1.71 | 90.7 | null | null | 2013-12-23 | Carboplatin + Etoposide IV 3 day | null | null | 260030068 | CISPLATIN + ETOPOSIDE |
| 260009528 | 260006136 | 1.8 | 137 | Palliative (P) | 2016-08-10 | 2016-09-04 | Carboplatin + Etoposide iv&po | 02 | N | 260030070 | BLEOMYCIN + VINCRISTINE |
| 260009529 | 260006136 | null | null | null | 2015-06-02 | 2015-06-09 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | N | N | 260030070 | EP |
| 260009530 | 260006137 | 1.65 | null | Palliative (P) | 2017-04-28 | 2017-05-10 | CETUXIMAB | 2 | N | 260030077 | BENDAMUSTINE |
| 260009531 | 260006137 | 1.59 | 62.5 | Curative (C) | null | 2016-10-28 | Rituximab | 02 | N | 260030077 | FCR |
| 260009532 | 260006138 | 1.82 | null | Curative (C) | null | 2017-05-25 | Carboplatin + Etoposide IV 3 day | N | null | 260030079 | CARBOPLATIN + PEMETREXED |
| 260009533 | 260006139 | 1.83 | 84.6 | Curative (C) | 2015-11-21 | 2015-11-25 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | 2 | 2 | 260030080 | CISPLATIN + ETOPOSIDE |
| 260009534 | 260006139 | 1.61 | 45.1 | Curative (C) | 2016-04-26 | 2016-04-26 | CHOP - 21 days | N | N | 260030080 | CARBOPLATIN + PACLITAXEL |
| 260009535 | 260006139 | 1.7 | 75.8 | Disease modification (D) | 2018-06-19 | 2018-06-22 | GEMCARBO | N | N | 260030080 | TRIAL |
| 260009536 | 260006140 | 1.68 | 111.8 | null | 2012-08-03 | 2013-09-21 | Cisplatin + Radiotherapy | N | N | 260030084 | CISPLATIN + RT |